Cargando…

Regulatory Flexibilities and Guidances for Addressing the Challenges of COVID-19 in the EU: What Can We Learn from Company Experiences?

The COVID-19 pandemic required urgency in the development and delivery of effective vaccines and therapeutics; meanwhile, ongoing clinical research, regulation and supply for other much-needed therapeutics and vaccines needed to be sustained. In Europe, the European Commission, the European Medicine...

Descripción completa

Detalles Bibliográficos
Autores principales:	Klein, Kevin, Stolk, Pieter, Tellner, Pär, Acha, Virginia, Montagne, Sarah, Stöckert, Isabelle
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8821789/ https://www.ncbi.nlm.nih.gov/pubmed/35129827 http://dx.doi.org/10.1007/s43441-022-00383-3

Ejemplares similares

The Global Landscape of Manufacturers of Follow-on Biologics: An Overview of Five Major Biosimilar Markets and 15 Countries
por: Klein, Kevin, et al.
Publicado: (2022)

Classification of Recombinant Biologics in the EU: Divergence Between National Pharmacovigilance Centers
por: Klein, Kevin, et al.
Publicado: (2015)

Changes in FDA enforcement activities following changes in federal administration: the case of regulatory letters released to pharmaceutical companies
por: Nguyen, Diane, et al.
Publicado: (2013)

Addressing Barriers to Organ Donor Research—A Renewed Call for Regulatory Guidance
por: Glazier, Alexandra K., et al.
Publicado: (2021)

The FDA guidance for industry on PROs: the point of view of a pharmaceutical company
por: Arpinelli, Fabio, et al.
Publicado: (2006)

Flexible and Expedited Regulatory Review Processes for Innovative Medicines and Regenerative Medical Products in the US, the EU, and Japan
por: Nagai, Sumimasa
Publicado: (2019)

Generational Diversity in the Workplace: Psychological Empowerment and Flexibility in Spanish Companies
por: Sobrino-De Toro, Ignacio, et al.
Publicado: (2019)

Pharmaceutical Company Targets and Strategies to Address Climate Change: Content Analysis of Public Reports from 20 Pharmaceutical Companies
por: Booth, Amy, et al.
Publicado: (2023)

EU guidance impedes humanitarian action to prevent COVID-19 in Syria
por: Hussain, Hamid Yahiya, et al.
Publicado: (2020)

Tobacco companies’ exploitation of loopholes in the EU ban on menthol cigarettes: a case study from Denmark
por: Brink, Anne-Line, et al.
Publicado: (2023)

The “EU chemicals strategy for sustainability” questions regulatory toxicology as we know it: is it all rooted in sound scientific evidence?
por: Herzler, Matthias, et al.
Publicado: (2021)

The EU’s GM crop conundrum: Did the EU policy strategy to convert EFSA GMO guidance into legislation deliver on its promises?
por: Garcia‐Alonso, Monica, et al.
Publicado: (2022)

CEO turnover and corporate innovation: What can we learn from Chinese listed companies
por: Sun, Shujun, et al.
Publicado: (2022)

Guidance for pediatric use in prescription information for novel medicinal products in the EU and the US
por: Christiansen, Helle, et al.
Publicado: (2022)

The FIRE AND ICE Trial: What We Know, What We Can Still Learn, and What We Need to Address in the Future
por: Kuck, Karl‐Heinz, et al.
Publicado: (2018)

The companies we keep: corporate governance for a democratic society
por: Hutchinson, Allan C
Publicado: (2005)

The Human Brand: How We Relate to People, Products, and Companies
por: Malone, Chris
Publicado: (2013)

Action guidance for addressing pollution from inhalational anaesthetics
por: Devlin‐Hegedus, J. A., et al.
Publicado: (2022)

The evolving EU regulatory framework for precision breeding
por: Eriksson, Dennis
Publicado: (2018)

Is law failing to address air pollution? Reflections on international and EU developments
por: Yamineva, Yulia, et al.
Publicado: (2017)

Action needed for the EU Common Agricultural Policy to address sustainability challenges
por: Pe'er, Guy, et al.
Publicado: (2020)

Knowing What We Know – Reflections on the Development of Technical Guidance for Loss Data for the Sendai Framework for Disaster Risk Reduction
por: Clarke, Lorcan, et al.
Publicado: (2018)

Management of post-acute COVID-19 patients in geriatric rehabilitation: EuGMS guidance
por: van Haastregt, Jolanda C. M., et al.
Publicado: (2021)

GitLab talk - Who we are (as a company), Roadmap and Vision
por: van der Voort, Job
Publicado: (2018)

The story of fake impact factor companies and how we detected them
por: Jalalian, Mehrdad
Publicado: (2015)

Fumonisins at Doses below EU Regulatory Limits Induce Histological Alterations in Piglets
por: Terciolo, Chloé, et al.
Publicado: (2019)

Regulatory Standards in Orphan Medicinal Product Designation in the EU
por: Tsigkos, Stelios, et al.
Publicado: (2021)

Ergot Alkaloids at Doses Close to EU Regulatory Limits Induce Alterations of the Liver and Intestine
por: Maruo, Viviane Mayumi, et al.
Publicado: (2018)

Challenges and Opportunities for the Traceability of (Biological) Medicinal Products
por: Klein, Kevin, et al.
Publicado: (2018)

Molecular Design of Luminescent Complexes of Eu(III): What Can We Learn from the Ligands
por: Romanova, Julia, et al.
Publicado: (2023)

EU Migration Pact Fails to Address Human Rights Concerns in Lesvos, Greece
por: Digidiki, Vasileia, et al.
Publicado: (2020)

Light-addressable Electrodes for Dynamic and Flexible Addressing of Biological Systems and Electrochemical Reactions
por: Welden, Rene, et al.
Publicado: (2020)

Guidance for the identification of endocrine disruptors in the context of Regulations (EU) No 528/2012 and (EC) No 1107/2009
por: Andersson, Niklas, et al.
Publicado: (2018)

Assessment of the endocrine disrupting properties of Bisphenol AF according to the EU criteria and ECHA/EFSA guidance
por: Escrivá, Laura, et al.
Publicado: (2019)

Review of Drug Development Guidance to Treat Chronic Obstructive Pulmonary Disease: US and EU Perspectives
por: van Haarst, Aernout, et al.
Publicado: (2019)

Human Biomonitoring Initiative (HBM4EU): Human Biomonitoring Guidance Values Derived for Dimethylformamide
por: Lamkarkach, Farida, et al.
Publicado: (2022)

The Application of Exercise Prescription Education in Medical Training
por: Sprys-Tellner, Thomas, et al.
Publicado: (2023)

Female obesity and infertility: outcomes and regulatory guidance
por: Marinelli, Susanna, et al.
Publicado: (2022)

Flexible spacecraft dynamics, control and guidance: technologies by giovanni campolo
por: Mazzini, Leonardo
Publicado: (2016)

Two Cases of Broncholith Removal under the Guidance of Flexible Bronchoscopy
por: Yi, Ka Yeoung, et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_u8ttaijes8d83ecgscj41lnq3g